Anthropic Q3 Revenue of $16.8B: What Is Claimed and What Is Verified

Related (October 28, 2026): the reported $40 trillion market claim, claimed vs verified.

Update (October 26, 2026): Anthropic has now filed its public S-1 (ticker ANT). See what the filing shows, the bubble question and the future of work.

Anthropic reportedly told prospective investors that its third-quarter revenue reached $16.8 billion, up about 45 percent from the second quarter, and that it was profitable on an adjusted basis. That is the claim. The verification is thinner than the headlines suggest: CNBC cites "people familiar with the matter," attributes the cash-flow detail to the Financial Times, and nothing has been filed publicly.

This post separates what is sourced from what is inferred, and then covers what it means if you build on Claude.

Update (October 15, 2026): the slower growth rate is what moved markets

Since this post went up, the story has shifted from the headline number to the growth rate. The Decoder, citing US media reports, The Information and the Financial Times, notes that roughly 45% quarter-over-quarter growth is well below Q2, when Claude Code demand pushed revenue up more than 140% over Q1. It says the figures reportedly "disappointed some potential investors," that some expect bankers to lower valuation expectations (possibly below $1.5 trillion, against $2 trillion floated earlier), and that Anthropic did not disclose a September annualized rate or a full-year outlook. It attributes part of the slowdown to a seasonal summer dip and to OpenAI's September launch of Astra; those are the outlet's explanations, not Anthropic's.

Market coverage on Thursday placed the number inside a broader risk-off mood. An Investing.com market wrap says US futures pointed lower after the S&P 500 and Nasdaq's biggest one-day drops since July, with hotter-than-expected September CPI and AI-valuation worries also in play. It quotes Vital Knowledge analysts saying cooling growth "undercuts sentiment" in a sector used to "parabolic figures." Other factors were clearly at work, so treat any "Anthropic caused the drop" framing as press narrative, not a verified cause. Nothing here changes the core verdict above: the figures remain unaudited and unfiled.

Update (October 15, 2026): the FT's own wording on margins and distillation

Simon Willison's write-up of the Financial Times report fills two gaps in the table above. We could not open the FT original ourselves, so this is as relayed by Willison.

• Margins: he reports that adjusted operating margins, excluding stock-based compensation, were 11%. That answers part of the "how is profitability defined" question: it is an adjusted figure that leaves out stock compensation, not GAAP.
• Distillation, now FT-sourced: the 5 to 7% figure is no longer only a headline summary. Willison quotes the FT as saying distillation "accounted for 5 per cent to 7 per cent of revenue," and that Anthropic cut it back "materially" in Q3. The FT attributes the information to four people with direct knowledge of the matter.
• Quarterly figures: his summary gives Q1 about $4.8bn, Q2 $11.5bn and Q3 $16.8bn, so the Q2 and Q1 numbers still differ slightly between outlets ($11.6bn and $4.7bn in CNBC's version).

Willison also does his own back-of-envelope arithmetic: if distillation was 5% of Q2 revenue, other labs spent more than half a billion dollars distilling Anthropic's models that quarter. That is his estimate, not a reported figure, and the FT does not say who the customers were or how Anthropic classified the usage. Our coverage of what Anthropic does about it is in the distillation defenses post.

TL;DR: claimed vs verified

What was actually reported

According to CNBC, Anthropic told investors that Q3 revenue "stands at $16.8 billion" and rose from $11.6 billion in Q2, with Q1 at $4.7 billion. It added that Anthropic said it was profitable on an adjusted basis and cash-flow positive, generating $1.70 in revenue for every dollar spent on computing power, according to the FT. CNBC also noted that investors expect $110 billion in annualized revenue by year-end, per the Wall Street Journal.

SiliconANGLE adds two caveats that matter. First, the FT's anonymous source did not say whether the number is gross or net revenue, or how the company defines profitability. Second, because Anthropic is still private, it does not have to release costs, so investors do not yet know how much is being spent to grow.

The figures were given at a private meeting with investors interested in the IPO. A Runtime Wire summary of the FT story says the report was independently corroborated by Reuters. We could not open the FT original, so the FT's wording here is as relayed by CNBC and SiliconANGLE.

What is not verified

• No filing. Our earlier coverage of the S-1 and banker meetings explains what a public filing would add: audited revenue, costs and share structure. Until then, every number here is a management statement relayed secondhand.
• Gross versus net. Cloud resale arrangements can make gross and net revenue very different. A $16.8B gross figure and a $16.8B net figure are different businesses.
• Adjusted profit. "Adjusted" can exclude stock compensation, training costs or one-time items. It is not comparable to the roughly $8B operating loss we covered for 2025 without a bridge.
• Growth rounding. The FT headline reportedly says up 50 percent; the arithmetic on the reported figures gives about 45 percent. Both are "roughly right," but cite one consistently.

Why the market is sensitive to this number

SiliconANGLE frames Anthropic's revenue as a bellwether for the wider AI market, and gives recent context. In May, Anthropic closed a $65 billion round at a reported $965 billion valuation. Last week, the FT revised its estimate of OpenAI's annualized revenue run rate down from about $68 billion to $50 billion, blaming a miscalculation by investigators; SiliconANGLE reports the Nasdaq fell 1.25 percent and shares of Oracle, CoreWeave, Intel and Nvidia fell more. That episode is a reminder of how much weight a single unaudited revenue number now carries, and why the gross-versus-net and run-rate-versus-recognized questions are not pedantry.

It is also why a claimed-versus-verified framing is the honest one. A correction of that size to a competitor's figure happened days ago, so a reader should expect that revenue numbers circulating before an S-1 can move, be restated or be defined differently by different outlets.

A short timeline of the reported numbers

Two things stand out. The Q1 figure already differs by $100 million between outlets, which shows how loosely these numbers are sourced even before the quarter in question. And all four rows are reported from conversations with investors, not from a regulator's database.

What readers keep asking

Is this a sign of an AI bubble or of a real business? The reports describe a large, fast-growing, adjusted-profitable company, but adjusted profit and anonymous sourcing leave the question open. Our AI bubble reality check lays out the longer-run arguments.

Does slowing growth mean Claude usage is falling? Nothing reported says so. Sequential growth of 45 percent is a rate, and revenue still rose by about $5 billion in the quarter.

Should I wait for the S-1 before choosing a model provider? For most teams the answer is no: pick on capability, price and terms, and keep your integration portable between providers so that a pricing change at any lab is a configuration edit, not a rewrite.

Reading the growth rate

Going from $4.7B in Q1 to $11.6B in Q2 is more than a doubling, about 147 percent. Going from $11.6B to $16.8B is about 45 percent. That deceleration is what the "slowing" headlines refer to, and it is normal arithmetic for a business that has already grown by an order of magnitude. A company that adds $5.2B in a quarter after adding $6.9B the quarter before is still adding enormous absolute revenue.

The $110B year-end figure deserves care. Our own arithmetic, not a reported number: Q3 at $16.8B is about $67B annualized, so reaching $110B annualized would require a late-year run rate roughly 60 percent above the Q3 average. That is a very large step, and it is an investor expectation reported by the WSJ, not a company target. The hype around it, including one aggregator's claim that the investor briefing "omitted" an outlook, is not something we could trace to a primary document. Treat any statement about what Anthropic did or did not say about its outlook as unconfirmed.

The distillation line

A separate report, from The Information as summarized in a Techmeme headline, says Anthropic told investors that distillation accounts for 5 to 7 percent of revenue, and that rapid but slowing growth could weigh on its IPO valuation. We were able to read only the headline summary, not the article.

The ambiguity matters. It could refer to revenue lost to, or associated with, other labs training on Claude outputs; it could refer to customers who license outputs for distillation; or it could be something else. Anthropic has been public about the problem: see our coverage of its new distillation defenses, the report that two Chinese labs secretly served Claude, the White House Moonshot discussion and the policy timeline on export controls and distillation. None of those gives a revenue percentage, so we have no independent anchor for the 5 to 7 percent figure.

What this means for what you build or pay

Finance news only earns space here when it touches builders, and this one does in three ways:

1. Capacity and limits. A company with $1.70 of revenue per dollar of compute has room to keep expanding capacity, but also a reason to hold the line on discounts and generous limits. Our compute-commitments explainer covers the obligations behind that ratio.
2. Pricing pressure from both sides. SiliconANGLE notes the shift to cheaper open-weight models and Anthropic's response with Claude Haiku 5.5, which it says costs around 75 percent less than Haiku 4.5. A growth slowdown plus a margin story ahead of listing could shape how aggressively prices fall.
3. Spend data tells a similar story. The Ramp AI Index for October shows Anthropic leading business spend while overall growth stalls, a consistent picture with a large but maturing revenue base.

How to check the numbers yourself

• Watch for the public S-1: it should define revenue recognition, the adjusted profit bridge and compute spending.
• Compare outlets' wording: "people familiar" at an investor meeting is different from a company statement.
• Check whether any figure is described as annualized run rate versus recognized quarterly revenue; the two get mixed in headlines.
• Treat any aggregator summary as a pointer, and follow it to the FT, Reuters, CNBC or WSJ original.

What to do now

If you depend on Claude in production, nothing in these reports requires action today. Keep an eye on the Claude pricing page, usage-limit notices and the model deprecation schedule rather than on valuation headlines. If your team uses agents with broad permissions on top of any provider, review them regardless of what quarterly revenue says; AgentBeam is the agent security platform from the explainx.ai team for stopping dangerous agent actions before they happen.

Related reading

• Anthropic Public Benefit Fund: 5% of shares committed, about 20% pledged in total

• NYC Comptroller Mark Levine asks Anthropic to pause its IPO over AI safety (October 15, 2026)

• Anthropic IPO path: S-1, banker meetings, and what changes for builders

• Anthropic draft prospectus: $16.3B H1 revenue, $80.7B loss, $450B compute

• Anthropic lost $8B operating in 2025

• Anthropic's reported $517B compute commitments

• Ramp AI Index, October 2026

• Anthropic's distillation defenses

• Chinese labs secretly serving Claude

Figures are as reported on October 15, 2026, from anonymous sources; they may be revised once Anthropic files publicly.